Clinical Trial Update: Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety study of CAT-8015 in advanced B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia has completed enrollment with results posted in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• CAT-8015

Snippet

Sponsor: MedImmune LLC | Conditions: Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-09